Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients E Heffler, C Crimi, S Mancuso, R Campisi, F Puggioni, L Brussino, N Crimi Respiratory medicine 142, 48-52, 2018 | 114 | 2018 |
Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer N Ciancio, MG Galasso, R Campisi, L Bivona, M Migliore, GU Di Maria Multidisciplinary respiratory medicine 7, 1-6, 2012 | 76 | 2012 |
Practical considerations for spirometry during the COVID-19 outbreak: Literature review and insights C Crimi, P Impellizzeri, R Campisi, S Nolasco, A Spanevello, N Crimi Pulmonology 27 (5), 438-447, 2021 | 74 | 2021 |
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients C Crimi, E Heffler, T Augelletti, R Campisi, A Noto, C Vancheri, N Crimi International journal of chronic obstructive pulmonary disease, 3131-3139, 2018 | 74 | 2018 |
Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype C Pelaia, C Crimi, G Pelaia, S Nolasco, R Campisi, E Heffler, G Valenti, ... Clinical & Experimental Allergy 50 (7), 780-788, 2020 | 65 | 2020 |
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report. L Spicuzza, A Montineri, R Manuele, C Crimi, MP Pistorio, R Campisi, ... The Journal of infection 81 (2), e53, 2020 | 62 | 2020 |
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco, R Campisi, S De Vuono, ... Thorax 78 (4), 354-361, 2023 | 58 | 2023 |
Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study S Nolasco, C Crimi, C Pelaia, A Benfante, MF Caiaffa, C Calabrese, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (12), 4371 …, 2021 | 54 | 2021 |
Bronchodilator response as a marker of poor asthma control E Heffler, C Crimi, R Campisi, S Sichili, G Nicolosi, M Porto, R Intravaia, ... Respiratory medicine 112, 45-50, 2016 | 52 | 2016 |
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities C Crimi, R Campisi, G Cacopardo, R Intravaia, S Nolasco, M Porto, ... World Allergy Organization Journal 13 (9), 100462, 2020 | 48 | 2020 |
The link between asthma and bronchiectasis: state of the art C Crimi, S Ferri, R Campisi, N Crimi Respiration 99 (6), 463-476, 2020 | 46 | 2020 |
Real-world experience with dupilumab in severe asthma: one-year data from an Italian named patient program R Campisi, C Crimi, S Nolasco, B Beghè, L Antonicelli, G Guarnieri, ... Journal of asthma and allergy, 575-583, 2021 | 44 | 2021 |
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study C Crimi, R Campisi, S Nolasco, G Cacopardo, R Intravaia, M Porto, ... Respiratory Medicine 185, 106491, 2021 | 43 | 2021 |
A retrospective study on acute health effects due to volcanic ash exposure during the eruption of Mount Etna (Sicily) in 2002 D Lombardo, N Ciancio, R Campisi, A Di Maria, L Bivona, V Poletti, ... Multidisciplinary respiratory medicine 8, 1-7, 2013 | 34 | 2013 |
Vitamin D and disease severity in bronchiectasis S Ferri, C Crimi, E Heffler, R Campisi, A Noto, N Crimi Respiratory Medicine 148, 1-5, 2019 | 29 | 2019 |
High flow nasal therapy use in patients with acute exacerbation of COPD and bronchiectasis: a feasibility study C Crimi, A Noto, A Cortegiani, R Campisi, E Heffler, C Gregoretti, N Crimi COPD: Journal of Chronic Obstructive Pulmonary Disease 17 (2), 184-190, 2020 | 27 | 2020 |
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis D Di Bona, C Crimi, AM D’Uggento, A Benfante, MF Caiaffa, C Calabrese, ... Clinical & Experimental Allergy 52 (2), 312-323, 2022 | 26 | 2022 |
Type 2-high severe asthma with and without bronchiectasis: a prospective observational multicentre study C Crimi, R Campisi, S Nolasco, S Ferri, G Cacopardo, P Impellizzeri, ... Journal of Asthma and Allergy, 1441-1452, 2021 | 26 | 2021 |
Adherence to omalizumab: A multicenter" real-world" study R Campisi, C Crimi, R Intravaia, S Strano, A Noto, MP Foschino, G Valenti, ... World Allergy Organization Journal 13 (2), 2020 | 26 | 2020 |
Comparability of asthma control test scores between self and physician-administered test C Crimi, R Campisi, A Noto, S Genco, G Cacopardo, S Nolasco, N Crimi Respiratory Medicine 170, 106015, 2020 | 25 | 2020 |